- Report
- February 2026
Global
From €5034EUR$5,550USD£4,276GBP
- Report
- September 2024
- 351 Pages
Global
From €3807EUR$4,197USD£3,234GBP
- Report
- July 2023
- 205 Pages
Global
From €5351EUR$5,899USD£4,545GBP
- Report
- March 2023
- 174 Pages
Global
From €1722EUR$1,899USD£1,463GBP
- Report
- June 2022
- 322 Pages
Global
From €4353EUR$4,799USD£3,698GBP
- Report
- May 2022
- 199 Pages
Global
From €4353EUR$4,799USD£3,698GBP
- Report
- May 2022
- 467 Pages
Global
From €4353EUR$4,799USD£3,698GBP
- Report
- April 2023
- 52 Pages
Global
From €4535EUR$5,000USD£3,852GBP
- Report
- April 2024
- 76 Pages
Global
From €1270EUR$1,400USD£1,079GBP
- Report
- September 2023
- 208 Pages
Global
From €3787EUR$4,175USD£3,217GBP
- Report
- January 2022
- 176 Pages
Global
From €4353EUR$4,799USD£3,698GBP
- Report
- June 2024
- 118 Pages
Global
From €4218EUR$4,650USD£3,583GBP
- Report
- April 2024
- 101 Pages
Global
From €4218EUR$4,650USD£3,583GBP
- Report
- August 2023
- 141 Pages
Global
From €4218EUR$4,650USD£3,583GBP
- Report
- July 2023
- 200 Pages
Global
From €4218EUR$4,650USD£3,583GBP
- Report
- November 2021
- 255 Pages
Global
From €4989EUR$5,500USD£4,238GBP
- Report
- September 2024
- 253 Pages
Global
From €4082EUR$4,500USD£3,467GBP
- Report
- February 2024
- 104 Pages
Europe
From €2676EUR$2,950USD£2,273GBP
- Report
- November 2023
- 101 Pages
Asia Pacific
From €1111EUR$1,225USD£944GBP
€2222EUR$2,450USD£1,888GBP
- Report
- April 2023
- 206 Pages
Global
From €3175EUR$3,500USD£2,697GBP
€6349EUR$7,000USD£5,393GBP

The MicroRNA market is a subset of the genomics industry that focuses on the study of small, non-coding RNA molecules. MicroRNAs are involved in a variety of biological processes, including gene expression, development, and disease. They are increasingly being studied as potential therapeutic targets for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders.
The market for microRNA-based therapeutics is growing rapidly, driven by advances in sequencing technology and the development of new delivery systems. Companies are developing a variety of products, including diagnostics, therapeutics, and research tools.
Some of the major players in the microRNA market include Thermo Fisher Scientific, Illumina, Qiagen, Merck, and Novartis. Other companies, such as Exiqon, Bio-Rad, and Bio-Techne, are also active in the market. Show Less Read more